- Home
- RSI vs VRDN Comparison
RSI vs VRDN Comparison
Compare RSI & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSI
- VRDN
- Stock Information
- Founded
- RSI 2012
- VRDN 2006
- Country
- RSI United States
- VRDN United States
- Employees
- RSI N/A
- VRDN N/A
- Industry
- RSI Services-Misc. Amusement & Recreation
- VRDN Medical Specialities
- Sector
- RSI Consumer Discretionary
- VRDN Health Care
- Exchange
- RSI Nasdaq
- VRDN Nasdaq
- Market Cap
- RSI 1.6B
- VRDN 1.6B
- IPO Year
- RSI N/A
- VRDN N/A
- Fundamental
- Price
- RSI $16.96
- VRDN $23.63
- Analyst Decision
- RSI Strong Buy
- VRDN Strong Buy
- Analyst Count
- RSI 9
- VRDN 10
- Target Price
- RSI $20.63
- VRDN $36.78
- AVG Volume (30 Days)
- RSI 1.8M
- VRDN 1.5M
- Earning Date
- RSI 10-29-2025
- VRDN 11-13-2025
- Dividend Yield
- RSI N/A
- VRDN N/A
- EPS Growth
- RSI N/A
- VRDN N/A
- EPS
- RSI 0.32
- VRDN N/A
- Revenue
- RSI $1,063,702,000.00
- VRDN $305,000.00
- Revenue This Year
- RSI $19.69
- VRDN N/A
- Revenue Next Year
- RSI $16.46
- VRDN $34,044.63
- P/E Ratio
- RSI $52.61
- VRDN N/A
- Revenue Growth
- RSI 23.15
- VRDN 5.90
- 52 Week Low
- RSI $9.54
- VRDN $9.90
- 52 Week High
- RSI $22.65
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- RSI 36.33
- VRDN 62.01
- Support Level
- RSI $16.68
- VRDN $21.65
- Resistance Level
- RSI $19.56
- VRDN $24.23
- Average True Range (ATR)
- RSI 1.09
- VRDN 1.11
- MACD
- RSI -0.17
- VRDN -0.03
- Stochastic Oscillator
- RSI 6.77
- VRDN 68.07
About RSI Rush Street Interactive Inc.
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).